论文信息 - Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant - 字舞流文

Dual mTOR Kinase Inhibitor MLN0128 Sensitizes HR+/HER2+ Breast Cancer Patient-Derived Xenografts to Trastuzumab or Fulvestrant

P. Chu | N. Kanaya | Shiuan Chen | Chun-Yu Liu | J. Mortimer | Pei-Yin Hsu | M. Kai | D. Schmolze | K. Petrossian | D. Nguyen | L. Kruper | C. Vito | Hang-Kai Hsu | Hannah Lu | Victoria Shang Wu | Hannah Lu | V. Wu